170 related articles for article (PubMed ID: 22778840)
1. Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expression.
Speed NK; Matthies HJ; Kennedy JP; Vaughan RA; Javitch JA; Russo SJ; Lindsley CW; Niswender K; Galli A
ACS Chem Neurosci; 2010 Jul; 1(7):476-81. PubMed ID: 22778840
[TBL] [Abstract][Full Text] [Related]
2. Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding.
Speed N; Saunders C; Davis AR; Owens WA; Matthies HJ; Saadat S; Kennedy JP; Vaughan RA; Neve RL; Lindsley CW; Russo SJ; Daws LC; Niswender KD; Galli A
PLoS One; 2011; 6(9):e25169. PubMed ID: 21969871
[TBL] [Abstract][Full Text] [Related]
3. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
Binda F; Dipace C; Bowton E; Robertson SD; Lute BJ; Fog JU; Zhang M; Sen N; Colbran RJ; Gnegy ME; Gether U; Javitch JA; Erreger K; Galli A
Mol Pharmacol; 2008 Oct; 74(4):1101-8. PubMed ID: 18617632
[TBL] [Abstract][Full Text] [Related]
4. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution.
Garcia BG; Wei Y; Moron JA; Lin RZ; Javitch JA; Galli A
Mol Pharmacol; 2005 Jul; 68(1):102-9. PubMed ID: 15795321
[TBL] [Abstract][Full Text] [Related]
5. Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine.
Williams JM; Owens WA; Turner GH; Saunders C; Dipace C; Blakely RD; France CP; Gore JC; Daws LC; Avison MJ; Galli A
PLoS Biol; 2007 Oct; 5(10):e274. PubMed ID: 17941718
[TBL] [Abstract][Full Text] [Related]
6. Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.
Ghisi V; Ramsey AJ; Masri B; Gainetdinov RR; Caron MG; Salahpour A
Cell Signal; 2009 Jan; 21(1):87-94. PubMed ID: 18929645
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.
Morón JA; Zakharova I; Ferrer JV; Merrill GA; Hope B; Lafer EM; Lin ZC; Wang JB; Javitch JA; Galli A; Shippenberg TS
J Neurosci; 2003 Sep; 23(24):8480-8. PubMed ID: 13679416
[TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter endocytic trafficking in striatal dopaminergic neurons: differential dependence on dynamin and the actin cytoskeleton.
Gabriel LR; Wu S; Kearney P; Bellvé KD; Standley C; Fogarty KE; Melikian HE
J Neurosci; 2013 Nov; 33(45):17836-46. PubMed ID: 24198373
[TBL] [Abstract][Full Text] [Related]
9. The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking.
Navaroli DM; Stevens ZH; Uzelac Z; Gabriel L; King MJ; Lifshitz LM; Sitte HH; Melikian HE
J Neurosci; 2011 Sep; 31(39):13758-70. PubMed ID: 21957239
[TBL] [Abstract][Full Text] [Related]
10. Insulin-modulated Akt subcellular localization determines Akt isoform-specific signaling.
Gonzalez E; McGraw TE
Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7004-9. PubMed ID: 19372382
[TBL] [Abstract][Full Text] [Related]
11. PI 3-kinase regulation of dopamine uptake.
Carvelli L; Morón JA; Kahlig KM; Ferrer JV; Sen N; Lechleiter JD; Leeb-Lundberg LM; Merrill G; Lafer EM; Ballou LM; Shippenberg TS; Javitch JA; Lin RZ; Galli A
J Neurochem; 2002 May; 81(4):859-69. PubMed ID: 12065645
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes.
Midde NM; Gomez AM; Zhu J
J Neuroimmune Pharmacol; 2012 Sep; 7(3):629-39. PubMed ID: 22570010
[TBL] [Abstract][Full Text] [Related]
13. Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression.
Cervinski MA; Foster JD; Vaughan RA
Neuroscience; 2010 Oct; 170(2):408-16. PubMed ID: 20643191
[TBL] [Abstract][Full Text] [Related]
14. Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system.
Barroso-Chinea P; Cruz-Muros I; Afonso-Oramas D; Castro-Hernández J; Salas-Hernández J; Chtarto A; Luis-Ravelo D; Humbert-Claude M; Tenenbaum L; González-Hernández T
Neurobiol Dis; 2016 Apr; 88():44-54. PubMed ID: 26777664
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism.
Wei Y; Williams JM; Dipace C; Sung U; Javitch JA; Galli A; Saunders C
Mol Pharmacol; 2007 Mar; 71(3):835-42. PubMed ID: 17164407
[TBL] [Abstract][Full Text] [Related]
16. The dopamine transporter is differentially regulated after dopaminergic lesion.
Afonso-Oramas D; Cruz-Muros I; Barroso-Chinea P; Álvarez de la Rosa D; Castro-Hernández J; Salas-Hernández J; Giráldez T; González-Hernández T
Neurobiol Dis; 2010 Dec; 40(3):518-30. PubMed ID: 20688165
[TBL] [Abstract][Full Text] [Related]
17. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism.
Bolan EA; Kivell B; Jaligam V; Oz M; Jayanthi LD; Han Y; Sen N; Urizar E; Gomes I; Devi LA; Ramamoorthy S; Javitch JA; Zapata A; Shippenberg TS
Mol Pharmacol; 2007 May; 71(5):1222-32. PubMed ID: 17267664
[TBL] [Abstract][Full Text] [Related]
18. In Situ Regulated Dopamine Transporter Trafficking: There's No Place Like Home.
Fagan RR; Kearney PJ; Melikian HE
Neurochem Res; 2020 Jun; 45(6):1335-1343. PubMed ID: 32146647
[TBL] [Abstract][Full Text] [Related]
19. Rescue of dopamine transporter function in hypoinsulinemic rats by a D2 receptor-ERK-dependent mechanism.
Owens WA; Williams JM; Saunders C; Avison MJ; Galli A; Daws LC
J Neurosci; 2012 Feb; 32(8):2637-47. PubMed ID: 22357848
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic Gq-coupled receptors drive biphasic dopamine transporter trafficking that modulates dopamine clearance and motor function.
Kearney PJ; Bolden NC; Kahuno E; Conklin TL; Martin GE; Lubec G; Melikian HE
J Biol Chem; 2023 Feb; 299(2):102900. PubMed ID: 36640864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
